Development of an injectable chitosan/marine collagen composite gel
Wei Wang1, Soichiro Itoh, Tomoyasu Aizawa
1Department of Inorganic Materials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan.
Biomedical Materials (Bristol, England)
|November 10, 2010
Summary
A novel chitosan/marine collagen composite gel shows controlled inflammatory responses and absorption in rats. This biomaterial is promising for tissue filler and drug delivery applications.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Chitosan and marine collagen are biocompatible polymers with potential in biomedical applications.
- Developing effective composite materials is crucial for advanced tissue regeneration and drug delivery.
Purpose of the Study:
- To develop and characterize a chitosan/marine-originated collagen composite gel.
- To evaluate the biocompatibility and inflammatory response of the composite gel after subcutaneous implantation in rats.
- To assess the potential of the composite gel as a carrier for tissue fillers and drug delivery systems.
Main Methods:
- A composite gel was prepared by mixing chitosan derivatives with salmon atelocollagen (SA) at various ratios.
- The composite gels were injected subcutaneously into rats, and specimens were harvested for histological analysis.
- Tumor necrosis factor-alpha (TNF-α) levels were measured using ELISA to assess inflammatory response.
Main Results:
- Composite gels with SA to chitosan ratios of 10:90 or 20:80 demonstrated controlled inflammatory cell infiltration and low TNF-α release.
- The implanted SA gel was absorbed within 2 weeks, followed by the gradual absorption of the chitosan component.
- Histological examination indicated subsequent soft tissue formation at the implantation site.
Conclusions:
- The developed chitosan/SA composite gel exhibits favorable biocompatibility and controlled degradation profiles.
- Optimized ratios of SA to chitosan can effectively modulate the inflammatory response.
- This composite gel holds significant potential as a carrier for tissue fillers and drug delivery systems.
